IPO registrations (S-1, F-1) · Underwriters
Tiger Securities
- Deals
- 4 priced offerings as an underwriter, 1 as lead manager or representative; 4 initial public offerings
- Proceeds of those deals
- $27,100,000 ($5,000,000 as lead)
- Years
- 2021–2025
- Named in
- 14 prospectuses and registration statements in all, including offerings not yet priced or withdrawn
- SEC registration
- Broker-dealer registered as TIGER SECURITIES, LLC · filings on EDGAR ↗
- Named as
- Tiger Securities; Tiger Securities Inc; Tiger Securities, Inc; TIGER SECURITIES, Inc
Deals by year
Deals 4
| Priced | Company | Role | Price | Range | Shares | Proceeds | Listing | Kind | Syndicate | Prospectus |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-08-28 | TryHard Holdings Ltd | Syndicate | $4.00 | 1,525,000 | $6,100,000 | Nasdaq THH | IPO | 3 | 424B4 ↗ | |
| 2025-06-26 | Julong Holding Ltd | Lead | $4.00 | 1,250,000 | $5,000,000 | Nasdaq JLHL | IPO | 3 | 424B4 ↗ | |
| 2024-10-01 | HomesToLife Ltd | Syndicate | $4.00 | 1,250,000 | $5,000,000 | Nasdaq HTLM | IPO | 3 | 424B4 ↗ | |
| 2021-06-25 | Bon Natural Life Ltd F4 | Syndicate | $5.00 | 2,200,000 | $11,000,000 | Nasdaq BON | IPO | 6 | 424B4 ↗ |
“Offering” is a priced registered offering that the cover page does not describe as an initial public offering: a follow-on, a resale, or a small company’s best-efforts deal.
Registrations in progress or never priced 7
| Filed | Company | Role | Range | Shares | Listing | Status | Document |
|---|---|---|---|---|---|---|---|
| 2026-10-30 | UCSB Acquisition Corp. | Lead | 6,000,000 | Nasdaq UCSB | Pending | S-1 ↗ | |
| 2026-06-09 | Cansince Innovations Inc. | Syndicate | 3,000,000 | KASH | Pending | F-1/A ↗ | |
| 2026-02-27 | APEX Global Solutions Ltd | Syndicate | 3,750,000 | Nasdaq APEX | Withdrawn 2026-02-25 | F-1 ↗ | |
| 2025-03-07 | Agroz Inc. | Lead | 1,500,000 | Effective 2025-03-31 | F-1/A ↗ | ||
| 2024-12-03 | Mountain&Sea Health Inc. | Syndicate | - | Nasdaq SYH | Pending | F-1 ↗ | |
| 2024-06-07 | UEOPLE Technology Holding Ltd | Lead | 26,250,000 | Pending | F-1 ↗ | ||
| 2021-05-20 | NUGENEREX IMMUNO-ONCOLOGY, INC. | Syndicate | 5,555,556 | Nasdaq NGIO | Pending | S-1/A ↗ |
Works alongside
| Firm | Deals together | Of which that firm led |
|---|---|---|
| Tiger Brokers | 4 | 2 |
| of Contents | 3 | 0 |
| F. Lafferty & Co., Inc | 1 | 1 |
| Joint Lead Bookrunning | 1 | 1 |
| Newbridge Securities Corporation | 1 | 0 |
| R.F. Lafferty | 1 | 0 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Offering terms are read from the cover pages of the registrant's final prospectus (424B4, 424B1) and its latest registration statement before pricing: the price range, the final price, shares offered, gross proceeds (the cover's total, else price times shares), exchange and ticker, and the underwriters named on the cover and in the underwriting table (loader/s1_terms.py). Underwriter names are normalised, so Goldman, Sachs & Co. of 1999 and Goldman Sachs & Co. LLC of 2024 are one firm.